Kinetics of procalcitonin in cardiogenic shock and in septic shock. Preliminary data

References

• Whicher J, Bienvenu J, Monneret G. Procalcitonin as an acute phase marker. Ann Clin Biochem. 2001;38:483–93.
   PubMed Web of Science ®Google Scholar
• Schneider HG, Lam QT. Procalcitonin for the clinical laboratory: A review. Pathology 2007;39:383–90.
   PubMed Web of Science ®Google Scholar
• Kafkas N, Venetsanou K, Patsilinakos S, Voudris V, Antonatos D, Kelesidis K, . Procalcitonin in acute myocardial infarction. Acute Card Care 2008;10:30–6.
   PubMedGoogle Scholar
• Geppert A, Steiner A, Delle-Karth G, Heinz G, Huber K. Usefulness of procalcitonin for diagnosing complicating sepsis in patients with cardiogenic shock. Intensive Care Med. 2003;29:1384–9.
   PubMed Web of Science ®Google Scholar
• Buratti T, Ricevuti G, Pechlaner C, Joannidis M, Wiedermann FJ, Gritti D, . Plasma levels of procalcitonin and interleukin-6 in IMA. Inflammation 2001;25:97–100.
   PubMed Web of Science ®Google Scholar
• Remskar M, Horvat M, Hojker S, Noc M. Procalcitonin in patients with acute myocardial infarction. Wien Klin Wochenschr. 2002;114:205–10.
   PubMed Web of Science ®Google Scholar
• Brunkhorst FM, Clark AL, Forycki ZF, Anker SD. Pyrexia, procalcitonin, immune activation and survival in cardiogenic shock: The potential importance of bacterial translocation. Int J Cardiol. 1999;72:3–10.
   PubMed Web of Science ®Google Scholar
• Picariello C, Lazzeri C, Chiostri M, Gensini G, Valente S. Procalcitonin in patients with acute coronary syndromes and cardiogenic shock submitted to percutaneous coronary intervention. Intern Emerg Med. 2009;4:403–408.
   PubMed Web of Science ®Google Scholar
• Seligman R, Mesner M, Lisboa TC, Hertz FT, Filippin TB, Fachel JM, . Decreases in procalcitonin and C-reactive protein are strong predictors of survival in ventilator associated pneumonia. Crit Care 2006;10:R125.
   PubMed Web of Science ®Google Scholar
• Hillas G, Vassilakopoulos T, Plantza P, Rasidakis A, Bakakos P. CRP and PCT as predictors of survival or septic shock in ventilatory associated pneumonia. Eur Respir J. 2010;35:805–811.
   PubMed Web of Science ®Google Scholar
• Califf RM, Bengtson JR. Cardiogenic shock. N Engl J Med. 1994;330:1724–30.
   PubMed Web of Science ®Google Scholar
• Hicks P, Cooper DJ. The Australian and New Zealand Intensive Care Society (ANZICS) Board and Clinical Trials Group Executive Committee. The surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Resusc. 2008;10:8.
   PubMedGoogle Scholar
• Holmes DR Jr. Cardiogenic shock. A lethal complication of acute myocardial infarction. Rev Cardiovasc Med. 2003;4:131–5.
   PubMedGoogle Scholar
• Hochman JS. Cardiogenic shock complicating acute myocardial infarction. Expanding the paradigm. Circulation 2003;107:2998–3002.
   PubMed Web of Science ®Google Scholar
• Webb JG, Lowe AM, Sanborn TA, White HD, Sleeper LA, Carere RG, . SHOCK Investigators. Percutaneous coronary intervention for cardiogenic shock in the SHOCK trial. J Am Coll Cardiol. 2003;42:1380–6.
   PubMed Web of Science ®Google Scholar
• Valente S, Lazzeri C, Vecchio S, Giglioli C, Margheri M, Bernardo P, . Predictors of in-hospital mortality after percutaneous coronary intervention for cardiogenic shock. Int J Cardiol. 2007;114:176–82.
   PubMed Web of Science ®Google Scholar
• Valente S, Lazzeri C, Chiostri M, Sori A, Giglioli C, Salvadori C, . Time of onset and outcome of cardiogenic shock in acute coronary syndromes. J Cardiovasc Med. (Hagerstown) 2008;9:1235–40.
   PubMed Web of Science ®Google Scholar
• Valente S, Lazzeri C, Chiostri M, Giglioli C, Sori A, Tigli S, . NT-proBNP on admission for early risk stratification in STEMI patients submitted to PCI. Relation with extension of STEMI and inflammatory markers. Int J Cardiol. 2009;132:84–9.
   PubMed Web of Science ®Google Scholar
• Knaus WA, Draper EA, Wagner DP, Zimmerman JE. “APACHE II: a severity of disease classification system”. Crit Care Med. 1985;13:818–29.
   PubMed Web of Science ®Google Scholar
• Sponholz C, Sakr Y, Reinhart K, Brunkhorst F. Diagnostic value and prognostic implications of serum procalcitonin after cardiac surgery: A systematic review of the literature. Crit Care Med. 2006;10:R145.
   Google Scholar
• Baykut D, Schulte-Herbrüggen J, Krian A. The value of procalcitonin as an infection marker in cardiac surgery. Eur J Med Res. 2000;5:530–6.
   PubMedGoogle Scholar
• Boeken U, Feindt P, Micek M, Petzold T, Schulte HD, Gams E. Procalcitonin (PCT) in cardiac surgery. Diagnostic value in systemic inflammatory response syndrome (SIRS), sepsis and after heart transplantation (HTX). Cardiovasc Surg. 2000;8:550–4.
   PubMedGoogle Scholar
• Rothenburger M, Markewitz A, Lenz T, Kaulbach HG, Marohl K, Kuhlmann WD, . Detection of acute phase response and infection. The role of procalcitonin and C-reactive protein. Clin Chem Lab Med. 1999;37:275–9.
   PubMed Web of Science ®Google Scholar
• Boeken U, Feindt P, Petzold T, Klein M, Micek M, Seyfert UT, . Diagnostic value of procalcitonin: The influence of cardiopulmonary bypass, aprotinin, SIRS, and sepsis. Thorac Cardiovasc Surg. 1998;46:348–51.
   PubMed Web of Science ®Google Scholar
• Prat C, Ricart P, Ruyra X, Domínguez J, Morillas J, Blanco S, . Serum concentration of procalcitonin after cardiac surgery. J Card Surg. 2008;23:627–32.
   PubMed Web of Science ®Google Scholar
• Aouifi A, Piriou V, Blanc P, Bouvier H, Bastien O, Chiari P, . Effect of cardiopulmonary bypass on serum procalcitonin and C-reactive protein concentrations. Br J Anaesth. 1999;83:602–7.
   PubMed Web of Science ®Google Scholar
• Meisner M, Rauschmayer C, Schmidt J, Feyrer R, Cesnjevar R, Bredle D, . Early increase of procalcitonin after cardiovascular surgery in patients with postoperative complications. Intensive Care Med. 2002;28:1094–102.
   PubMed Web of Science ®Google Scholar
• Aouifi A, Piriou V, Bastien O, Blanc P, Bouvier H, Evans R, . Usefulness of procalcitonin for diagnosis of infection in cardiac surgical patients. Crit Care Med. 2000;28:3171–6.
   PubMed Web of Science ®Google Scholar
• Adamik B, Kübler-Kielb J, Golebiowska B, Gamian A, Kübler A. Effect of sepsis and cardiac surgery with cardiopulmonary bypass on plasma level of nitric oxide metabolites, neopterin, and procalcitonin: Correlation with mortality and postoperative complications. Intensive Care Med. 2000;26:1259–567.
   PubMed Web of Science ®Google Scholar
• Madershahian N, Wittwer T, Strauch J, Wippermann J, Rahmanian P, Franke UF, . Kinetic of procalcitonin in the early postoperative course following heart transplantation. J Card Surg. 2008;23:468–73.
   PubMed Web of Science ®Google Scholar
• Dandona P, Nix D, Wilson MF, Aljada A, Love J, Assicot M, . Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab. 1994; 79:1605–8.
   PubMed Web of Science ®Google Scholar
• Maruna P, Nedelnikova R, Gurlich R. Physiology and genetics of procalcitonin. Physiol Res. 2000;49 Suppl. 1:S57–61.
   PubMed Web of Science ®Google Scholar
• Molnár Z, Bogár L. Let's go dynamic with procalcitonin! Crit Care Med. 2006;34:2687–8.
   PubMed Web of Science ®Google Scholar
• Jensen JU, Heslet L, Jensen TH, Espersen K, Steffensen P, Tvede M. Procalcitonin increase in early identification of critically ill patients at high risk of mortality. Crit Care Med. 2006;34:2596–602.
   PubMed Web of Science ®Google Scholar
• Jarai R, Fellner B, Haoula D, Jordanova N, Heinz G, Karth GD, . Early assessment of outcome in cardiogenic shock. Relevance of plasma N-terminal pro-B-type natriuretic peptide and interleukin-6 levels. Crit Care Med. 2009;37:1837–44.
   PubMed Web of Science ®Google Scholar
• Gibot S, Cravoisy A, Kolopp-Sarda MN, Bene MC, Faure G, Bollaert PE, . Time-course of sTREM (soluble triggering receptor expressed on myeloid cells)-1, procalcitonin, and Creactive protein plasma concentrations during sepsis. Crit Care Med. 2005;33:792–6.
   PubMed Web of Science ®Google Scholar
• Meisner M, Tschaikowsky K, Palmaers T, Schmidt J. Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different sofa scores during the course of sepsis and mods. Crit Care 1999;3:45–50.
   PubMed Web of Science ®Google Scholar
• Luyt CE, Guerin V, Combes A, Trouillet JL, Ayed SB, Bernard M, . Procalcitonin kinetics as a prognostic marker of ventilator-associated pneumonia. Am J Respir Crit Care Med. 2005;171:48–53.
   PubMed Web of Science ®Google Scholar
• Clec'h C, Ferriere F, Karoubi P, Fosse JP, Cupa M, Hoang P, . Diagnostic and prognostic value of procalcitonin in patients with septic shock. Crit Care Med. 2004;32:1166–9.
   PubMed Web of Science ®Google Scholar